ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The biobased chemical developer BioAmber has laid out plans to build a 100,000-metric-ton-per-year 1,4-butanediol plant in North America. BioAmber has signed a 15-year agreement under which the chemical distributor Vinmar International will invest in the plant and buy its output. BioAmber CEO Jean-François Huc says the agreement should attract other investors to the facility, which he hopes to open in 2017. The plant will convert sugar-derived succinic acid into butanediol using a process BioAmber licensed from DuPont; BioAmber is building a succinic acid plant in Sarnia, Ontario.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter